ZA885250B - A method for preparing stable and viable recombinant animal cell viral vectors - Google Patents

A method for preparing stable and viable recombinant animal cell viral vectors

Info

Publication number
ZA885250B
ZA885250B ZA885250A ZA885250A ZA885250B ZA 885250 B ZA885250 B ZA 885250B ZA 885250 A ZA885250 A ZA 885250A ZA 885250 A ZA885250 A ZA 885250A ZA 885250 B ZA885250 B ZA 885250B
Authority
ZA
South Africa
Prior art keywords
animal cell
viral vectors
recombinant animal
viable recombinant
preparing stable
Prior art date
Application number
ZA885250A
Other languages
English (en)
Inventor
Lynn William Enquist
William Enquist Lynn
Alan Keith Robbins
Keith Robbins Alan
Brian Lee Sauer
Lee Sauer Brian
Mary Elaine Whealy
Elaine Whealy Mary
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of ZA885250B publication Critical patent/ZA885250B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16751—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA885250A 1987-07-21 1988-07-20 A method for preparing stable and viable recombinant animal cell viral vectors ZA885250B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7714587A 1987-07-21 1987-07-21

Publications (1)

Publication Number Publication Date
ZA885250B true ZA885250B (en) 1990-03-28

Family

ID=22136338

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885250A ZA885250B (en) 1987-07-21 1988-07-20 A method for preparing stable and viable recombinant animal cell viral vectors

Country Status (10)

Country Link
EP (1) EP0300422B1 (fr)
JP (1) JPH01112986A (fr)
KR (1) KR890002404A (fr)
AT (1) ATE83008T1 (fr)
AU (1) AU610608B2 (fr)
DE (1) DE3876327D1 (fr)
DK (1) DK405288A (fr)
IL (1) IL87170A0 (fr)
NZ (1) NZ225470A (fr)
ZA (1) ZA885250B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569679B1 (en) 1988-03-21 2003-05-27 Chiron Corporation Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene
US6133029A (en) 1988-03-21 2000-10-17 Chiron Corporation Replication defective viral vectors for infecting human cells
US5716826A (en) * 1988-03-21 1998-02-10 Chiron Viagene, Inc. Recombinant retroviruses
US5997859A (en) * 1988-03-21 1999-12-07 Chiron Corporation Method for treating a metastatic carcinoma using a conditionally lethal gene
DE69033975T2 (de) * 1989-01-23 2002-10-02 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Rekombinanttherapien für Infektionen und hyperproliferative Störungen
AU648261B2 (en) * 1989-08-18 1994-04-21 Novartis Vaccines And Diagnostics, Inc. Recombinant retroviruses delivering vector constructs to target cells
JP3203599B2 (ja) * 1989-10-24 2001-08-27 カイロン コーポレイション 感染性タンパク質デリバリーシステム
US5849572A (en) * 1990-10-10 1998-12-15 Regents Of The University Of Michigan HSV-1 vector containing a lat promoter
US5849571A (en) * 1990-10-10 1998-12-15 University Of Pittsburgh Of The Commonwealth System Of Higher Education Latency active herpes virus promoters and their use
US6120764A (en) * 1993-06-24 2000-09-19 Advec, Inc. Adenoviruses for control of gene expression
CA2117668C (fr) * 1994-03-09 2005-08-09 Izumu Saito Adenovirus recombinant et son mode de production
US5888814A (en) * 1994-06-06 1999-03-30 Chiron Corporation Recombinant host cells encoding TNF proteins
JP4216350B2 (ja) * 1994-09-19 2009-01-28 大日本住友製薬株式会社 動物細胞感染用の組換えｄｎａウイルスベクター
US6825012B2 (en) 1995-02-23 2004-11-30 Gencell S.A. DNA molecules, preparation and use in gene therapy
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique
JP3770333B2 (ja) * 1995-03-15 2006-04-26 大日本住友製薬株式会社 組換えｄｎａウイルスおよびその製造方法
US6964861B1 (en) 1998-11-13 2005-11-15 Invitrogen Corporation Enhanced in vitro recombinational cloning of using ribosomal proteins
US6974694B2 (en) 1995-06-07 2005-12-13 Advec, Inc. Adenoviruses for control of gene expression
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
EP2322614A1 (fr) * 1995-06-07 2011-05-18 Life Technologies Corporation Clonage de recombinaison au moyen de sites de recombinaison obtenus par génie génétique
US6143557A (en) 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
FR2737501B1 (fr) * 1995-07-31 1997-10-24 Transgene Sa Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants
FR2737731B1 (fr) * 1995-08-07 1997-10-10 Pasteur Institut Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote
AU726724B2 (en) * 1995-08-07 2000-11-16 Institut Pasteur Sequence of natural or synthetic retroelements enabling nucleotide sequence insertion into a eukaryotic cell
DE19530412A1 (de) * 1995-08-18 1997-02-20 Harald Von Prof Dr Melchner Selbst deletierende retrovirale Vektoren für die Gentherapie
WO1997019181A2 (fr) * 1995-11-24 1997-05-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Vecteur de virus utile pour transferer des episomes stables
AU2319497A (en) 1996-03-07 1997-09-22 Regents Of The University Of California, The Helper-free, totally defective adenovirus for gene therapy
US6132989A (en) * 1996-06-03 2000-10-17 University Of Washington Methods and compositions for enhanced stability of non-adenoviral DNA
US6534314B1 (en) 1996-06-14 2003-03-18 Massachusetts Institute Of Technology Methods and compositions for transforming cells
US5928914A (en) * 1996-06-14 1999-07-27 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Methods and compositions for transforming cells
US5851808A (en) 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
EP1025217B1 (fr) 1997-10-24 2006-10-04 Invitrogen Corporation Clonage recombinatoire au moyen d'acides nucleiques possedant des sites de recombinaison
US7351578B2 (en) 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
CN101125873A (zh) * 1997-10-24 2008-02-20 茵维特罗根公司 利用具重组位点的核酸进行重组克隆
AU1536999A (en) * 1997-11-26 1999-06-15 Board Of Regents, The University Of Texas System Modified sv40 viral vectors
EP1173460B1 (fr) 1999-03-02 2009-09-16 Life Technologies Corporation Compositions et methodes de clonage recombinatoire d'acides nucleiques
NZ539430A (en) 1999-12-10 2006-09-29 Invitrogen Corp Use of multiple recombination sites with unique specificity in recombinational cloning
US7244560B2 (en) 2000-05-21 2007-07-17 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
WO2005054438A2 (fr) 2003-12-01 2005-06-16 Invitrogen Corporation Molecule d'acide nucleique contenant des sites de recombinaison et leurs procedes d'utilisation

Also Published As

Publication number Publication date
EP0300422B1 (fr) 1992-12-02
AU1920188A (en) 1989-01-27
ATE83008T1 (de) 1992-12-15
IL87170A0 (en) 1988-12-30
EP0300422A2 (fr) 1989-01-25
KR890002404A (ko) 1989-04-10
AU610608B2 (en) 1991-05-23
JPH01112986A (ja) 1989-05-01
DK405288A (da) 1989-01-22
EP0300422A3 (en) 1990-02-28
DK405288D0 (da) 1988-07-20
DE3876327D1 (de) 1993-01-14
NZ225470A (en) 1990-06-26

Similar Documents

Publication Publication Date Title
ZA885250B (en) A method for preparing stable and viable recombinant animal cell viral vectors
YU44962B (en) Process for obtaining recombinant bovine pre-growth hormone in an microorganism
GB8610600D0 (en) Transformation of trichoderma
DE68922216D1 (de) Zellenzuchtverfahren in bioreaktoren.
CZ776486A3 (en) Process for preparing heterologous protein within a transformed cell
IL75554A (en) Matrix for cell cultivation in vitro
HUT39564A (en) Process for the incapsulation of biological pesticides in cells
GR870601B (en) Process for preparing a storage stable concentrate
HUT58798A (en) Process for producing growth factor of parenchimic hepatic celles, the gen for coding this and transformants for producing this factor
DK440083A (da) Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmaader til fremstilling af svinevaeksthormonlignende polypeptider
EP0197474A3 (en) Process for preparing optically active indoline-2-carboxylic acid
DK579983D0 (da) Fremgangsmaade til fremstilling af et polypeptid med oksevaeksthormonaktivitet samt rekombinant dna-vektor og encellede organismer til brug herved
EP0329094A3 (en) Cell culture tank
GB8822870D0 (en) Cell culture vial
NO175318C (no) Hybridgen for veksthormonfrigjörende faktor, replikerbar mikrobiell ekspresjonsvektor inneholdende et slikt gen, samt mikroorganisme transformert med en slik vektor og hybridpolypeptid som inneholder en Trp-GRF
NO175872C (no) Plasmidvektor, fremgangsmåte for fremstilling av peptider og myelomcelle
GB8716997D0 (en) Cell culture vessel
DE3781385D1 (de) Elektrochemische zelle mit behaelterunterstuetzung.
EP0380689A4 (en) Process for preparing optically active 2-hydroxy-4-phenyl-3-butenoic acid
PT83619B (en) Process for preparing optically active acyloxyazetidinones
IL84629A0 (en) Process and device for the cultivation of mammalian cells in a suspension culture,and their use for the preparation of proteins
IE882214L (en) An improved method for preparing stable and viable recombinant animal cell viral vectors
DE3368628D1 (en) Process for preparing p.chlorophenoxyacetyl-piperonylpiperazine
GB8709499D0 (en) Cell culture processes
GB8724922D0 (en) Bubble cell culture